Sariaslani Advances in Applied Microbiology

1. Auflage 2009
ISBN: 978-0-08-095104-1
Verlag: Elsevier Science & Techn.
Format: EPUB
Kopierschutz: 6 - ePub Watermark

E-Book, Englisch, 300 Seiten

Reihe: ISSN

Published since 1959, Advances in Applied Microbiology continues to be one of the most widely read and authoritative review sources in microbiology.
The series contains comprehensive reviews of the most current research in applied microbiology. Recent areas covered include bacterial diversity in the human gut, protozoan grazing of freshwater biofilms, metals in yeast fermentation processes and the interpretation of host-pathogen dialogue through microarrays.
Eclectic volumes are supplemented by thematic volumes on various topics, including Archaea and sick building syndrome. Impact factor for 2007: 1.821.
* Contributions from leading authorities and industry experts
* Informs and updates on all the latest developments in the field
* Reference and guide for scientists and specialists involved in advancements in applied microbiology

Autoren/Hrsg.

Sariaslani, Sima

Inhaltsverzeichnis

1;Front Cover;1
2;Advances in Applied Microbiology;2
3;Copyright Page;5
4;Contents;7
5;Contributions;11
6;Chapter 1: Bacterial L-Forms;13
6.1;I. Introduction;14
6.2;II. Definition and Characteristics of L-Forms;15
6.2.1;A. Definition of L-forms;15
6.2.2;B. Induction and cultivation;18
6.3;III. Significance of L-Forms;21
6.3.1;A. Contributions to bacterial cell division;22
6.3.2;B. Contributions to membrane organisation;26
6.3.3;C. Biotechnology;30
6.3.4;D. L-form interaction and association with eukaryotes;33
6.4;IV. Conclusions;43
6.5;Acknowledgments;43
6.6;References;43
7;Chapter 2: Biochemistry, Physiology and Biotechnology of Sulfate-Reducing Bacteria;53
7.1;I. Introduction;55
7.2;II. Diversity of SRB;56
7.2.1;A. Distribution in the environment;56
7.2.2;B. Major characteristics;57
7.3;III. Central Metabolic Pathways of SRB;58
7.3.1;A. Sulfur metabolism;58
7.3.2;B. Nitrogen metabolism;61
7.3.3;C. Hydrogen metabolism;63
7.3.4;D. Oxygen metabolism;64
7.3.5;E. Fermentation of organic substrates;65
7.3.6;F. Fermentation of inorganic sulfur compounds;65
7.3.7;G. Carbon metabolism;66
7.4;IV. Characteristics of Electron Transfer Proteins;66
7.4.1;A. Soluble electron transfer proteins;66
7.4.2;B. Membrane-associated electron transport complexes;70
7.5;V. Environmental Impact of SRB;71
7.5.1;A. Biocorrosion of ferrous metals;71
7.5.2;B. Corrosion of concrete and stonework;74
7.5.3;C. Impact on the petroleum industry;75
7.6;VI. Biotechnology of SRB;77
7.6.1;A. Bioremediation of organic compounds;77
7.6.2;B. Immobilization of toxic metals;84
7.6.3;C. Reduction of azo dyes;93
7.6.4;D. Recovery of precious metals;94
7.7;VII. Perspective;96
7.8;Acknowledgments;96
7.9;References;96
8;Chapter 3: Biotechnological Applications of Recombinant Microbial Prolidases;111
8.1;I. Introduction;112
8.2;II. Prolidase;115
8.2.1;A. Mechanism of substrate specificity and catalysis;115
8.2.2;B. Proposed reaction mechanism;117
8.2.3;C. Structure-function information provided by the solved Pyrococcus furiosus prolidase structure;118
8.2.4;D. Molecular and catalytic properties of recombinant prolidases;121
8.3;III. Applications of Prolidases;123
8.3.1;A. Detoxification of OP compounds;123
8.3.2;B. Uses in the food industry;128
8.3.3;C. Impact on human health;130
8.4;IV. Advances in and Limitations of the Use of Prolidase for Biotechnological Applications;133
8.5;V. Conclusions;135
8.6;Acknowledgments;135
8.7;References;136
9;Chapter 4: The Capsule of the Fungal Pathogen Cryptococcus neoformans;145
9.1;I. Introduction;146
9.2;II. Capsule Components and Structure;148
9.2.1;A. Structure of capsular components;150
9.2.2;B. Capsule dynamics;157
9.3;III. Capsule Synthesis in Cryptococcus;166
9.3.1;A. Genes, enzymes and signaling pathways;166
9.3.2;B. GXM traffic in C. neoformans;178
9.3.3;C. Polysaccharide connections at the C. neoformans surface;182
9.4;IV. Capsule Functions in C. neoformans: The Capsule as a Virulence Factor: Function During the Interaction with the Host;184
9.4.1;A. Role of the capsule during interaction with the host;184
9.4.2;B. Role of the exopolysaccharides during infection;190
9.4.3;C. Origin of the capsule as virulence factor;200
9.5;V. Use of Capsular Components as Antifungal Targets and Vaccine;202
9.5.1;A. Capsule as an antifungal target: mAbs to the capsule as therapeutic alternative;202
9.5.2;B. Use of capsular components as vaccine;206
9.6;VI. Future Perspectives;207
9.7;Acknowledgments;208
9.8;References;208
10;Chapter 5: Baculovirus Interactions In Vitro and In Vivo;229
10.1;I. Introduction;230
10.2;II. Baculovirus Infection Process;231
10.3;III. Baculovirus Interactions;232
10.4;IV. Baculovirus Interactions In Vitro;233
10.4.1;A. Antagonistic interactions;233
10.4.2;B. Neutralistic interactions;242
10.5;V. Baculoviruses Interactions In Vivo;244
10.5.1;A. Neutralism;244
10.5.2;B. Mutualism;245
10.5.3;C. Antagonism;246
10.6;VI. Conclusions;247
10.7;VII. Future Prospects;247
10.8;Acknowledgments;247
10.9;References;248
11;Chapter 6: Posttranscriptional Gene Regulation in Kaposi's Sarcoma-Associated Herpesvirus;253
11.1;I. Introduction;254
11.2;II. KSHV-Encoded miRNAs;255
11.2.1;A. Discovery and conservation of KSHV-encoded miRNAs;256
11.2.2;B. Targets of KSHV miRNAs;257
11.2.3;C. KSHV miR-K12-11 is an ortholog of miR-155;257
11.3;III. ORF57, A Multifunctional Regulator of Gene Expression;258
11.3.1;A. ORF57 stimulates the export of intronless viral mRNAs;259
11.3.2;B. ORF57 affects transcription and RNA stability;260
11.3.3;C. ORF57 enhances viral pre-mRNA splicing;262
11.4;IV. SOX Destabilizes Cellular mRNAs;262
11.5;V. Kaposin B Stabilizes AU-Rich mRNAs;263
11.6;VI. The PAN-ENE is a cis-acting RNA Stability Element;264
11.7;VII. Summary;265
11.8;Acknowledgment;266
11.9;References;266
12;Index;275
13;Contents of Previous Volumes;281
14;Color Plates;293